The levonorgestrel intrauterine system: A clinical perspective from the UK

Annals of the New York Academy of Sciences

Volumn 997, Issue , 2003, Pages 185-193

  Guillebaud, John ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Margaret Pyke Centre   (United Kingdom)

Author keywords

Contraception; Intrauterine; Intrauterine device (IUD); Intrauterine system (IUS); Levonorgestrel (LNG); Pelvic infection; Uterine bleeding

Indexed keywords

ANTIBIOTIC AGENT; GESTAGEN; LEVONORGESTREL; CONTRACEPTIVE AGENT;

AGING; AMENORRHEA; ANTIBIOTIC PROPHYLAXIS; CLIMACTERIUM; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG RELEASE; DRUG USE; DYSMENORRHEA; ECTOPIC PREGNANCY; ENDOCRINE DISEASE; ESTROGEN THERAPY; FEMALE FERTILITY; FEMALE STERILIZATION; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LOW DRUG DOSE; MENORRHAGIA; PELVIC INFLAMMATORY DISEASE; SAFETY; UTERUS BLEEDING; ADULT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CONTRACEPTION; EVALUATION; FEMALE; INCIDENCE; METHODOLOGY; MIDDLE AGED; PREGNANCY; PREGNANCY RATE; REVIEW; RISK ASSESSMENT; STANDARD; UNITED KINGDOM;

ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DOSE-RESPONSE RELATIONSHIP, DRUG; EVALUATION STUDIES; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MIDDLE AGED; PELVIC INFECTION; PREGNANCY; PREGNANCY RATE; RISK ASSESSMENT; UTERINE HEMORRHAGE;

EID: 0642303158     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1290.021     Document Type: Conference Paper

References (17)

1. ANDERSSON, K., V. ODLIND & G. RYBO. 1994. Levonorgestrel-releasing and copper releasing (Nova-T) IUDs during five years of use: a randomised comparative trial. Contraception 49: 56-72.
2. SIVIN, I. & J. STERN. 1994. Health during prolonged use of levonorgestrel 20 mcg/d and the Copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. Fertil. Steril. 61: 70-77.
3. FARLEY, T. et al. 1992. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339: 785-788.
4. GRIMES, D. 2000. Intrauterine device and upper-genital-tract infection. Lancet 356: 1013-1019.
5. GUILLEBAUD, J. 2001. Intrauterine devices and infertility. Lancet 358: 1460.
6. WESTERGAARD, L., T. PHILIPSEN & J. SCHEIBEI. 1982. Significance of cervical chlamydia trachomatis infection in postabortal pelvic inflammatory disease. Obstet Gynecol. 60: 322-325.
7. WALSH, T. et al. 1998. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. Lancet 351: 1005-1008.
8. DENNIS, J. & N. HAMPTON. 2002. IUDs: which device? (Rev.). J. Fam. Plann. Reprod. Health Care 28: 61-68.
9. LETHABY, A., I. COOKE & M. REES. 2000. Progesterone/progestogen releasing intrauterine systems versus either placebo or any medication for heavy menstrual bleeding (Cochrane Review). The Cochrane library. Issue 4. Oxford: Update Software.
10. LAHTEENMAKI, P. et al. 1998. Open randomised study of use of levonorgestrel-releasing IUS as an alternative to hysterectomy. BMJ 316: 1122-1126.
11. KITTELSEN, N. & O. ISTRE. 1998. A randomised study comparing levonogestrel intrauterine system (LNG IUS) and transcervical resection of die endometrium (TCRE) in the treatment of menorrhagia: preliminary results. Gynaecol. Endoscopy 7: 61-65.
12. SUVISAARI, J. & P. LAHTEENMAKI. 1996. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception 55: 201-208.
13. FRENCH, R. et al. 2000. Correspondence on levonorgestrel-releasing intra-uterine systems (Mirena) compared with other methods of reversible contraception. Br. J. Obstet. Gynaecol. 107: 771.
14. BACKMAN, T. et al. 2000. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: nation-wide study of 17,360 users. Br. J. Obstet. Gyaecol. 107: 335-339.
15. SUHONEN, S., T. HOLMSTROM & P. LAHTEENMAKI. 1997. Three-year follow-up of the use of a levonorgestrel-releasing intrauterine system in hormone replacement therapy. Acta Obstet. Gynecol. Scand. 76: 145-150.
16. STURRIDGE, F. & J. GUILLEBAUD. 1997. Gynaecological aspects of the levonorgestrel-releasing intrauterine system (Rev.). Br. J. Obstet. Gynaecol. 104: 285-289.
17. WILDEMEERSCH, D., M. DHONT, S. WEYERS, AND M. TEMMERMAN. 2003. Miniature, Low-Dose, Intrauterine Drug-Delivery Systems. This volume.